๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Do we need to determine viral genotype in treating chronic hepatitis B?

โœ Scribed by W. G. E. Cooksley


Book ID
108886471
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
79 KB
Volume
17
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Chronic liver disease and cirrhosis amon
โœ Ana Mota; Jorge Areias; Margarida Fonseca Cardoso ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 85 KB ๐Ÿ‘ 2 views

## Abstract The prevalence of infection with hepatitis B virus in Portugal is around 1% of the population; 20โ€“30% of those infected typically develop cirrhosis. The study focuses on the epidemiological profile of patients with hepatitis B infection and liver damage, in particular, cirrhosis. Of the

A mutation in the interferon sensitivity
โœ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 178 KB ๐Ÿ‘ 2 views

## Abstract The interferon sensitivityโ€determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japanโ€specific subtype (Jโ€type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon